IBRANCE is a prescription breast cancer medicine used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (advanced).1 It is taken in combination with: an aromatase inhibitor or fulvestrant in women who have received prior endocrine therapy.1 Women who haven’t been through menopause may also receive a luteinizing hormone releasing agonist in combination with endocrine therapy.1 Talk to your healthcare team to see if IBRANCE is right for you.